ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study
Study sponsor: ACADIA Pharmaceuticals Inc. · ACAD
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2029-04Estimated
Enrollment · participants752Estimated
Source updated2026-11-04Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.